Across Africa, a new malaria drug for newborns and young infants is being hailed as a breakthrough, one that could save tens of thousands of lives each year.
The medicine is already approved in eight African countries. But in Liberia, where malaria remains one of the leading killers of children, health officials say it may take years to arrive.
In this collaboration with SpoonFM, Nemenlah Cyrus Harmon tells us, what that delay could mean for families already living on the edge.

This story was a collaboration with New Narratives as part of the Investigating Liberia Project. Funding was provided by the Swedish Embassy in Liberia. The funder had no say in the story’s content.